XML 31 R21.htm IDEA: XBRL DOCUMENT v3.21.1
Stockholders' Equity (Tables)
6 Months Ended
Mar. 31, 2021
Equity [Abstract]  
Schedule of Stock-Based Compensation Expense Related to Stock Options and RSUs The following table summarizes stock-based compensation expense related to RSUs, stock options, and ESPP shares, which was allocated as follows (amounts shown in thousands):
Three Months Ended March 31,Six Months Ended March 31,
 2021202020212020
Cost of revenue$82 $65 $169 $126 
Selling and marketing892 594 1,680 1,166 
Research and development777 680 1,517 1,354 
General and administrative1,217 969 2,349 1,965 
Stock-based compensation expense included in expenses
$2,968 $2,308 $5,715 $4,611 
Schedule of Stock Option Activity
The following table summarizes stock option activity under the Company’s equity plans during the six months ended March 31, 2021:
Number of
Shares
Weighted-Average
Exercise Price
Weighted-Average
Remaining
Contractual Term
(in Years)
Aggregate Intrinsic Value
(in thousands)
Outstanding at September 30, 20201,162,505 $7.51 6.1$6,081 
Granted— $— 
Exercised(259,865)$7.54 
Canceled— $— 
Outstanding at March 31, 2021902,640 $7.50 6.0$11,368 
Vested and Expected to Vest at March 31, 2021902,640 $7.50 6.0$11,368 
Exercisable at March 31, 2021625,015 $6.61 5.2$4,979 
Schedule of RSU Activity
The following table summarizes RSU activity under the Company’s equity plans during the six months ended March 31, 2021:
 
Number of
Shares
Weighted-Average
Fair Market Value
Per Share
Outstanding at September 30, 20202,661,943 $7.95 
Granted706,412 $12.27 
Settled(845,420)$7.39 
Canceled(77,635)$9.20 
Outstanding at March 31, 20212,445,300 $9.35 
Schedule of Performance RSU Activity
Performance Restricted Stock Units
The following table summarizes Performance RSU activity under the Company’s equity plans during the six months ended March 31, 2021:
 
Number of
Shares
Weighted-Average
Fair Market Value
Per Share
Outstanding at September 30, 2020353,556 $6.06 
Granted284,765 $11.84 
Settled(90,345)$6.06 
Canceled— $— 
Outstanding at March 31, 2021547,976 $10.06